Company: FTII
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001641172-25-011790
Chunk: 45

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Item 8
Chunk 45
---
2024 to January 18, 2025. On January 18, 2025, the Company caused to
be deposited $37,744 into the Company’s Trust account, allowing the Company to extend the period of time it has to consummate
its initial Business Combination from January 18, 2025 to February 18, 2025. On February 18, 2025, the Company caused to be
deposited $37,744 into the Company’s Trust account, allowing the Company to extend the period of time it has to consummate its
initial Business Combination from February 18, 2025 to March 18, 2025. On March 18, 2025, the Company caused to be deposited $37,744
into the Company’s Trust account, allowing the Company to extend the period of time it has to consummate its initial Business
Combination from March 18, 2025 to April 18, 2025. On April 18, 2025, the Company caused to be deposited $45,244 (consisting of $38,994 for the Extension Loan
for the period from April 18, 2025 to May 18, 2025 and $6,250 of additional amount for previous five (5) extension periods taking into
account reversed redemptions after the Third Extension of the Combination Period on November 18, 2024) into the Company’s Trust
account, allowing the Company to extend the period of time it has to consummate its initial Business Combination from April 18, 2025 to
May 18, 2025. On May 20, 2025, the Company caused to be deposited $38,994 into the Company’s Trust account, allowing
the Company to extend the period of time it has to consummate its initial Business Combination from May 18, 2025 to June 18, 2025.

As of December 31, 2024,
there was $3,537,744 outstanding under the Extension Loans from the Sponsor. As of March 31, 2025, there was $3,537,744 outstanding under
the Extension Loans from the Sponsor.

 5 

Business Combination; Merger Agreement with
Longevity Biomedical Inc.

On September 16, 2024, the
Company, entered into a Merger Agreement”, by and among the Company, Longevity, LBI Merger Sub, Inc., and